https://m2.mtmt.hu/ hun 2026-05-31 01:51 JournalArticle 35731852 VALIDATED true 0 false 2026-05-24T15:21:27.413+0000 2026-05-07T11:23:25.696+0000 2025-02-02T21:30:58.098+0000 true 10077410 Juhász Vencel /api/author/10077410 Author Juhász Vencel (Kardiológia, Sportorvostan) true 2026-05-07T11:14:31.242+0000 2026-05-07T11:14:31.242+0000 2026-05-07T11:23:25.864+0000 true 10062062 Gere Tamásné /api/admin/10062062 Admin Gere Tamásné (SE_KK_Admin5_GT, admin) true 10062062 true false true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle true 10000059 Article true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle /api/subtype/10000059 Szakcikk SubType Szakcikk (Folyóiratcikk) 101 true 10000059 true 1 /api/category/1 Category Tudományos true 1 Juhász, Vencel true true /api/journal/20085158 REVIEWED JACC. CARDIOONCOLOGY 2666-0873 2666-0873 true false false 20085158 true 2666-0873 2666-0873 Journal FOREIGN 7 2 125 137 125 13 2025 Funding 2049928 /api/funding/2049928 (ÚNKP-23-4-II-SE) false true true true 2025 true true true false true false GOLD 2026-05-24 false https://www.sciencedirect.com/journal/jacc-cardiooncology 11 0 11 8 3 11 11 11 9 11 11 8 8 8 3 0 11 8 11 8 0 2 2 Folyóiratcikk Journal Article 24 11 Könyvrészlet Chapter in Book 25 0 Könyv Book 23 0 Egyéb konferenciaközlemény Conference paper 31 0 Egyéb konferenciakötet Conference proceedings 32 0 Oltalmi formák Protection forms 26 0 Disszertáció Thesis 28 0 Egyéb Miscellaneous 29 0 Alkotás Achievement 22 0 Kutatási adat Research data 33 0 Folyóiratcikk Journal Article 24 0 0 0 Könyvrészlet Chapter in Book 25 0 0 0 Könyv Book 23 0 0 0 Egyéb konferenciaközlemény Conference paper 31 0 0 0 Egyéb konferenciakötet Conference proceedings 32 0 0 0 Oltalmi formák Protection forms 26 0 0 0 Disszertáció Thesis 28 0 0 0 Egyéb Miscellaneous 29 0 0 0 Alkotás Achievement 22 0 0 0 Kutatási adat Research data 33 0 0 0 2025 0 6 5 6 5 2026 0 5 3 5 3 D1 false false false false 2025-02-18T10:18:18.718+0000 Városmajori Szív- és Érgyógyászati Klinika (SE / AOK / K) 2 14 1 15 0 true Language 10002 /api/language/10002 Angol Angol English true 2 true PersonAuthorship 123076669 /api/authorship/123076669 Juhász, Vencel [Juhász, Vencel (Kardiológia, Spor...), szerző] Városmajori Szív- és Érgyógyászati Klinika (SE / AOK / K) 1 0.067 true false false Author 10077410 /api/author/10077410 Juhász Vencel (Kardiológia, Sportorvostan) Juhász Vencel true true Juhász Vencel true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 123076670 /api/authorship/123076670 Quinaglia, Thiago 2 0.06666667 false false false Quinaglia Thiago true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 123076671 /api/authorship/123076671 Drobni, Zsófia D. [Drobni, Zsófia (kardiológia), szerző] Városmajori Szív- és Érgyógyászati Klinika (SE / AOK / K) 3 0.067 false false false Author 10061268 /api/author/10061268 Drobni Zsófia (kardiológia) Drobni Zsófia true 10061268 true Drobni Zsófia D. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 123076672 /api/authorship/123076672 Heemelaar, Julius C. 4 0.06666667 false false false Heemelaar Julius C. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 123076673 /api/authorship/123076673 Neuberg, Donna S. 5 0.06666667 false false false Neuberg Donna S. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 123076674 /api/authorship/123076674 Han, Yuchi 6 0.06666667 false false false Han Yuchi true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 123076675 /api/authorship/123076675 Ky, Bonnie 7 0.06666667 false false false Ky Bonnie true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 123076676 /api/authorship/123076676 Kwong, Raymond Y. 8 0.06666667 false false false Kwong Raymond Y. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 123076677 /api/authorship/123076677 Januzzi, James L. 9 0.06666667 false false false Januzzi James L. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 123076678 /api/authorship/123076678 Asnani, Aarti 10 0.06666667 false false false Asnani Aarti true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 123076679 /api/authorship/123076679 Redd, Robert A. 11 0.06666667 false false false Redd Robert A. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 123076680 /api/authorship/123076680 Mousavi, Negareh 12 0.06666667 false false false Mousavi Negareh true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 123076681 /api/authorship/123076681 Jerosch-Herold, Michael 13 0.06666667 false false false Jerosch-Herold Michael true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 123076682 /api/authorship/123076682 Scherrer-Crosbie, Marielle 14 0.06666667 false false false Scherrer-Crosbie Marielle true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 123076683 /api/authorship/123076683 Neilan, Tomas G. ✉ 15 0.067 false true true Neilan Tomas G. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PublicationIdentifier 28329013 /api/publicationidentifier/28329013 DOI: 10.1016/j.jaccao.2024.11.008 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true IDENTICAL 10.1016/j.jaccao.2024.11.008 https://doi.org/10.1016/j.jaccao.2024.11.008 false true PublicationIdentifier 28674103 /api/publicationidentifier/28674103 WoS: 001430139600001 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 001430139600001 https://www.webofscience.com/wos/woscc/full-record/001430139600001 true true PublicationIdentifier 28428852 /api/publicationidentifier/28428852 Scopus: 85217117879 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 85217117879 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85217117879 true true PublicationIdentifier 28674135 /api/publicationidentifier/28674135 PubMed: 39967198 PlainSource 17 /api/publicationsource/17 PubMed PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true PubMed PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract true true 17 true IDENTICAL 39967198 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=39967198&dopt=Abstract true true Classification 12139 /api/classification/12139 Szív és érrendszer true true SjrRating 11563305 /api/sjrrating/11563305 sjr:D1 (2025) Scopus - Cardiology and Cardiovascular Medicine JACC. CARDIOONCOLOGY 2666-0873 2666-0873 13 0.1 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 2705 /api/classificationexternal/2705 Scopus - Cardiology and Cardiovascular Medicine true 2705 true D1 DIRECT true true Reference 62833113 /api/reference/62833113 1. Lyon 2022: 2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)., Eur Heart J, 43, p. 4229, DOI: 10.1093/eurheartj/ehac244 1 10.1093/eurheartj/ehac244 false true Reference 62833114 /api/reference/62833114 2. Jensen 2002: Functional monitoring of anthracycline cardiotoxicity: a prospective, blinded, long-term observational study of outcome in 120 patients., Ann Oncol, 13, p. 699, DOI: 10.1093/annonc/mdf132 2 10.1093/annonc/mdf132 false true Reference 62833115 /api/reference/62833115 3. Cardinale 2015: Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy., Circulation, 131, p. 1981, DOI: 10.1161/CIRCULATIONAHA.114.013777 3 10.1161/CIRCULATIONAHA.114.013777 false true Reference 62833116 /api/reference/62833116 4. Tan 2015: Anthracycline-induced cardiomyopathy in adults., Compr Physiol, 5, p. 1517, DOI: 10.1002/cphy.c140059 4 10.1002/cphy.c140059 false true Reference 62833117 /api/reference/62833117 5. Neilan 2023: Atorvastatin for anthracycline-associated cardiac dysfunction: the STOP-CA randomized clinical trial., JAMA, 330, p. 528, DOI: 10.1001/jama.2023.11887 5 10.1001/jama.2023.11887 false true Reference 62833118 /api/reference/62833118 6. Schelbert 2015: Myocardial fibrosis quantified by extracellular volume is associated with subsequent hospitalization for heart failure, death, or both across the spectrum of ejection fraction and heart failure stage., J Am Heart Assoc, 4 6 false true Reference 62833119 /api/reference/62833119 7. Galán-Arriola 2019: Serial magnetic resonance imaging to identify early stages of anthracycline-induced cardiotoxicity., J Am Coll Cardiol, 73, p. 779, DOI: 10.1016/j.jacc.2018.11.046 7 10.1016/j.jacc.2018.11.046 false true Reference 62833120 /api/reference/62833120 8. Farhad 2016: Characterization of the changes in cardiac structure and function in mice treated with anthracyclines using serial cardiac magnetic resonance imaging., Circ Cardiovasc Imaging, 9, DOI: 10.1161/CIRCIMAGING.115.003584 8 10.1161/CIRCIMAGING.115.003584 false true Reference 62833121 /api/reference/62833121 9. Neilan 2013: Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy., Am J Cardiol, 111, p. 717, DOI: 10.1016/j.amjcard.2012.11.022 9 10.1016/j.amjcard.2012.11.022 false true Reference 62833122 /api/reference/62833122 10. Folco 2023: MRI-derived extracellular volume as a biomarker of cancer therapy cardiotoxicity: systematic review and meta-analysis., Eur Radiol, 34, p. 2699, DOI: 10.1007/s00330-023-10260-8 10 10.1007/s00330-023-10260-8 false true Reference 62833123 /api/reference/62833123 11. Ferreira de Souza 2018: Anthracycline therapy is associated with cardiomyocyte atrophy and preclinical manifestations of heart disease., JACC Cardiovasc Imaging, 11, p. 1045, DOI: 10.1016/j.jcmg.2018.05.012 11 10.1016/j.jcmg.2018.05.012 false true Reference 62833124 /api/reference/62833124 12. Jordan 2016: Anthracycline-associated T1 mapping characteristics are elevated independent of the presence of cardiovascular comorbidities in cancer survivors., Circ Cardiovasc Imaging, 9, DOI: 10.1161/CIRCIMAGING.115.004325 12 10.1161/CIRCIMAGING.115.004325 false true Reference 62833125 /api/reference/62833125 13. Heck 2018: Effect of candesartan and metoprolol on myocardial tissue composition during anthracycline treatment: the PRADA trial., Eur Heart J Cardiovasc Imaging, 19, p. 544, DOI: 10.1093/ehjci/jex159 13 10.1093/ehjci/jex159 false true Reference 62833126 /api/reference/62833126 14. Oh 2020: Atorvastatin protects cardiomyocyte from doxorubicin toxicity by modulating survivin expression through FOXO1 inhibition., J Mol Cell Cardiol, 138, p. 244, DOI: 10.1016/j.yjmcc.2019.12.007 14 10.1016/j.yjmcc.2019.12.007 false true Reference 62833127 /api/reference/62833127 15. Ramanjaneyulu 2013: Protective role of atorvastatin against doxorubicin-induced cardiotoxicity and testicular toxicity in mice., J Physiol Biochem, 69, p. 513 15 false true Reference 62833128 /api/reference/62833128 16. Riad 2009: Pretreatment with statin attenuates the cardiotoxicity of doxorubicin in mice., Cancer Res, 69, p. 695, DOI: 10.1158/0008-5472.CAN-08-3076 16 10.1158/0008-5472.CAN-08-3076 false true Reference 62833129 /api/reference/62833129 17. Cerqueira 2002: Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association., J Am Soc Echocardiogr, 15, p. 463, DOI: 10.1067/mje.2002.123374 17 10.1067/mje.2002.123374 false true Reference 62833130 /api/reference/62833130 18. Wong 2012: Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality., Circulation, 126, p. 1206, DOI: 10.1161/CIRCULATIONAHA.111.089409 18 10.1161/CIRCULATIONAHA.111.089409 false true Reference 62833131 /api/reference/62833131 19. Wong 2013: Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission., Eur Heart J, 35, p. 657, DOI: 10.1093/eurheartj/eht193 19 10.1093/eurheartj/eht193 false true Reference 62833132 /api/reference/62833132 20. Acar 2011: Efficiency of atorvastatin in the protection of anthracycline-induced cardiomyopathy., J Am Coll Cardiol, 58, p. 988, DOI: 10.1016/j.jacc.2011.05.025 20 10.1016/j.jacc.2011.05.025 false true Reference 62833133 /api/reference/62833133 21. Nabati 2019: Effect of rosuvastatin in preventing chemotherapy-induced cardiotoxicity in women with breast cancer: a randomized, single-blind, placebo-controlled trial., J Cardiovasc Pharmacol Ther, 24, p. 233, DOI: 10.1177/1074248418821721 21 10.1177/1074248418821721 false true Reference 62833134 /api/reference/62833134 22. Hundley 2022: Statins and left ventricular ejection fraction following doxorubicin treatment., NEJM Evidence, 1, DOI: 10.1056/EVIDoa2200097 22 10.1056/EVIDoa2200097 false true Reference 62833135 /api/reference/62833135 23. Thavendiranathan 2023: Statins to prevent early cardiac dysfunction in cancer patients at increased cardiotoxicity risk receiving anthracyclines., Eur Heart J Cardiovasc Pharmacother, 9, p. 515, DOI: 10.1093/ehjcvp/pvad031 23 10.1093/ehjcvp/pvad031 false true Reference 62833136 /api/reference/62833136 24. Makhlin 2024: Statins do not significantly affect oxidative nitrosative stress biomarkers in the PREVENT randomized clinical trial., Clin Cancer Res, 30, p. 2370, DOI: 10.1158/1078-0432.CCR-23-3952 24 10.1158/1078-0432.CCR-23-3952 false true Reference 62833137 /api/reference/62833137 25. Kim 2012: Cardioprotective effects of rosuvastatin and carvedilol on delayed cardiotoxicity of doxorubicin in rats., Toxicol Mech Methods, 22, p. 488, DOI: 10.3109/15376516.2012.678406 25 10.3109/15376516.2012.678406 false true Reference 62833138 /api/reference/62833138 26. Zhang 2012: Identification of the molecular basis of doxorubicin-induced cardiotoxicity., Nat Med, 18, p. 1639, DOI: 10.1038/nm.2919 26 10.1038/nm.2919 false true Reference 62833139 /api/reference/62833139 27. Cadour 2023: Prognostic value of cardiovascular magnetic resonance T1 mapping and extracellular volume fraction in nonischemic dilated cardiomyopathy., J Cardiovasc Magn Reson, 25, p. 7, DOI: 10.1186/s12968-023-00919-y 27 10.1186/s12968-023-00919-y false true Reference 62833140 /api/reference/62833140 28. Everett 2020: Extracellular myocardial volume in patients with aortic stenosis., J Am Coll Cardiol, 75, p. 304, DOI: 10.1016/j.jacc.2019.11.032 28 10.1016/j.jacc.2019.11.032 false true Reference 62833141 /api/reference/62833141 29. Rubiś 2021: Extracellular volume is an independent predictor of arrhythmic burden in dilated cardiomyopathy., Sci Rep, 11, DOI: 10.1038/s41598-021-03452-z 29 10.1038/s41598-021-03452-z false true Reference 62833142 /api/reference/62833142 30. Treibel 2020: Extracellular volume associates with outcomes more strongly than native or post-contrast myocardial T1., JACC Cardiovasc Imaging, 13, p. 44, DOI: 10.1016/j.jcmg.2019.03.017 30 10.1016/j.jcmg.2019.03.017 false true Reference 62833143 /api/reference/62833143 31. Park 2021: Ultrahigh-field cardiovascular magnetic resonance T1 and T2 mapping for the assessment of anthracycline-induced cardiotoxicity in rat models: validation against histopathologic changes., J Cardiovasc Magn Reson, 23, p. 76, DOI: 10.1186/s12968-021-00767-8 31 10.1186/s12968-021-00767-8 false true Reference 62833144 /api/reference/62833144 32. Meléndez 2017: Progressive 3-month increase in LV myocardial ECV after anthracycline-based chemotherapy., JACC Cardiovasc Imaging, 10, p. 708, DOI: 10.1016/j.jcmg.2016.06.006 32 10.1016/j.jcmg.2016.06.006 false true Reference 62833145 /api/reference/62833145 33. Miller 2013: Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume., Circ Cardiovasc Imaging, 6, p. 373, DOI: 10.1161/CIRCIMAGING.112.000192 33 10.1161/CIRCIMAGING.112.000192 false true Reference 62833146 /api/reference/62833146 34. Hundley 2018: When left ventricular extracellular volume fraction changes after anthracyclines: is it due to a change in the numerator, denominator, or both?., JACC Cardiovasc Imaging, 11, p. 1056, DOI: 10.1016/j.jcmg.2018.06.006 34 10.1016/j.jcmg.2018.06.006 false true Reference 62833147 /api/reference/62833147 35. Coelho-Filho 2013: Quantification of cardiomyocyte hypertrophy by cardiac magnetic resonance: implications for early cardiac remodeling., Circulation, 128, p. 1225, DOI: 10.1161/CIRCULATIONAHA.112.000438 35 10.1161/CIRCULATIONAHA.112.000438 false true Reference 62833148 /api/reference/62833148 36. Gulati 2017: Neurohormonal blockade and circulating cardiovascular biomarkers during anthracycline therapy in breast cancer patients: Results from the PRADA (Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy) study., J Am Heart Assoc, 6 36 false true Reference 62833149 /api/reference/62833149 37. Gulati 2016: Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol., Eur Heart J, 37, p. 1671, DOI: 10.1093/eurheartj/ehw022 37 10.1093/eurheartj/ehw022 false true Reference 62833150 /api/reference/62833150 38. Bhatia 2020: Genetics of anthracycline cardiomyopathy in cancer survivors: JACC: CardioOncology state-of-the-art review., JACC CardioOncol, 2, p. 539, DOI: 10.1016/j.jaccao.2020.09.006 38 10.1016/j.jaccao.2020.09.006 false true Reference 62833151 /api/reference/62833151 39. Larsen 2023: Association of anthracycline with heart failure in patients treated for breast cancer or lymphoma, 1985-2010., JAMA Netw Open, 6, DOI: 10.1001/jamanetworkopen.2022.54669 39 10.1001/jamanetworkopen.2022.54669 false true Reference 62833152 /api/reference/62833152 40. Abdel-Qadir 2021: Statin exposure and risk of heart failure after anthracycline-or trastuzumab-based chemotherapy for early breast cancer: a propensity score–matched cohort study., J Am Heart Assoc, 10, p. 1 40 false true Reference 62833153 /api/reference/62833153 41. Seicean 2012: Effect of statin therapy on the risk for incident heart failure in patients with breast cancer receiving anthracycline chemotherapy: An observational clinical cohort study., J Am Coll Cardiol, 60, p. 2384, DOI: 10.1016/j.jacc.2012.07.067 41 10.1016/j.jacc.2012.07.067 false true Reference 62833154 /api/reference/62833154 42. Neilan 2012: Left ventricular mass in patients with a cardiomyopathy after treatment with anthracyclines., Am J Cardiol, 110, p. 1679, DOI: 10.1016/j.amjcard.2012.07.040 42 10.1016/j.amjcard.2012.07.040 false true Reference 62833155 /api/reference/62833155 43. Nakamori 2018: Native T1 mapping and extracellular volume mapping for the assessment of diffuse myocardial fibrosis in dilated cardiomyopathy., JACC Cardiovasc Imaging, 11, p. 48, DOI: 10.1016/j.jcmg.2017.04.006 43 10.1016/j.jcmg.2017.04.006 false true Reference 62833156 /api/reference/62833156 44. Martin-Garcia 2020: T2 mapping identifies early anthracycline-induced cardiotoxicity in elderly patients with cancer., JACC Cardiovasc Imaging, 13, p. 1630, DOI: 10.1016/j.jcmg.2020.01.017 44 10.1016/j.jcmg.2020.01.017 false true Reference 62833157 /api/reference/62833157 45. Lustberg 2019: Early detection of anthracycline-induced cardiotoxicity in breast cancer survivors with T2 cardiac magnetic resonance., Circ Cardiovasc Imaging, 12, DOI: 10.1161/CIRCIMAGING.118.008777 45 10.1161/CIRCIMAGING.118.008777 false true Reference 62833158 /api/reference/62833158 46. Nielsen 2012: Statin use and reduced cancer-related mortality., N Engl J Med, 367, p. 1792, DOI: 10.1056/NEJMoa1201735 46 10.1056/NEJMoa1201735 false true Reference 62833159 /api/reference/62833159 47. Balaji 2023: Racial disparity in anthracycline-induced cardiotoxicity in breast cancer patients., Biomedicines, 11, p. 2286, DOI: 10.3390/biomedicines11082286 47 10.3390/biomedicines11082286 false true Reference 62833160 /api/reference/62833160 48. Prasad 2020: Cardio-oncology preventive care: racial and ethnic disparities., Curr Cardiovasc Risk Rep, 14, DOI: 10.1007/s12170-020-00650-8 48 10.1007/s12170-020-00650-8 false true /api/publication/35731852 Juhász Vencel et al. Atorvastatin and Myocardial Extracellular Volume Expansion During Anthracycline-Based Chemotherapy. (2025) JACC. CARDIOONCOLOGY 2666-0873 2666-0873 7 2 125-137<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png"> <div class="autype autype0"> <span class="author-name" mtid="10077410"><a href="/gui2/?type=authors&mode=browse&sel=10077410" target="_blank">Juhász Vencel (<span class="authorship-author-name">Juhász Vencel</span> <span class="authorAux-mtmt"> Kardiológia, Sportorvostan</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Városmajori Szív- és Érgyógyászati Klinika</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Quinaglia Thiago </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10061268"><a href="/gui2/?type=authors&mode=browse&sel=10061268" target="_blank">Drobni Zsófia D. (<span class="authorship-author-name">Drobni Zsófia</span> <span class="authorAux-mtmt"> kardiológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Városmajori Szív- és Érgyógyászati Klinika</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Heemelaar Julius C. </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Neuberg Donna S. </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Han Yuchi </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Ky Bonnie </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Kwong Raymond Y. </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Januzzi James L. </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Asnani Aarti </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Redd Robert A. </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Mousavi Negareh </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Jerosch-Herold Michael </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Scherrer-Crosbie Marielle </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Neilan Tomas G. ✉ </span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;35731852" target="_blank">Atorvastatin and Myocardial Extracellular Volume Expansion During Anthracycline-Based Chemotherapy</a></div> <div> <span class="journal-title">JACC. CARDIOONCOLOGY</span> <span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/2666-0873">2666-0873</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/2666-0873">2666-0873</a>)</span>: <span class="journal-volume">7</span> <span class="journal-issue">2</span> <span class="page"> pp 125-137 </span> <span class="year">(2025)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Nyelv: Angol | </span> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="10.1016/j.jaccao.2024.11.008" target="_blank" href="https://doi.org/10.1016/j.jaccao.2024.11.008"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="001430139600001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/001430139600001"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85217117879" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85217117879"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="39967198" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=39967198&dopt=Abstract"> PubMed </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Folyóirat szakterülete: Scopus - Cardiology and Cardiovascular Medicine&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;D1</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Oncology&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;D1</div> </div></OnlyViewableByAuthor> <div class="publication-citation" style="margin-left: 0.5cm;"> <span title="Nyilvános idézőközlemények összesen, említések nélkül" class="citingPub-count">Nyilvános idéző összesen: 11</span> | Független: 8 | Függő: 3 | Nem jelölt: 0 | WoS jelölt: 11 | Scopus jelölt:&nbsp;9 | WoS/Scopus jelölt:&nbsp;11 | DOI jelölt:&nbsp;11 </div> <div class="publication-citation"> <a target="_blank" href="/api/publication?cond=citations.related;eq;35731852&sort=publishedYear,desc&sort=title"> Idézett közlemények száma: 2 </a> </div> <div class="mtid"><span class="long-pub-mtid">Közlemény: 35731852</span> | <span class="status-data status-VALIDATED"> Egyeztetett </span> Forrás Idéző | <span class="type-subtype">Folyóiratcikk ( Szakcikk ) </span> | <span class="pub-category">Tudományos</span> | <span class="publication-sourceOfData">kézi felvitel</span> </div> <div class="funder"> (ÚNKP-23-4-II-SE) </div> <div class="lastModified">Utolsó módosítás: 2026.05.07. 13:23 Gere Tamásné (SE_KK_Admin5_GT, admin) </div> </div></div>